ヒト Germline 遺伝子検査の現状と今後の課題(1)

司会のことば

小　杉　眞　司*1　上　田　國　寛*2
　　　　　　　　　　　　　　　　　　　　　　
Human Germline Genetic Tests : Present and Future
−Chairmen's Introductory Remarks

Shinji KOSUGI, MD*1 and Kunikane UEDA, MD*2

We had a symposium on this subject in the Kinki sub-division of the Society of Japanese Clinical Pathology on June 8th at Kyoto because the laboratory tests in this field are now near the clinical application. We focused on the three major fields of genetic tests ; �@ neurodegenerative diseases as most typical Mendelian disorders, �A diabetes mellitus as a typical common disease, and �B familial tumor syndromes which can be prevented relatively easily by presymptomatic testing. Further, we also discussed the infrastructure for gene tests and ELSIs(ethical, legal and social issues) of the gene tests.
[Rinsho Byori 50 : 869〜870, 2002]

*2Department of Clinical Genetics and Department of Laboratory Medicine, Kyoto University School of Medicine, Kyoto 606-8507

【Key Words】neurodegenerative disorders(神経変性疾患)，common diseases(生活習慣病)，familial tumor(家族性腫瘍)，ethical, legal and social issues：ELSI(倫理的法的社会的問題)，genetic medicine(遺伝子診療)

*1京都大学臨床病態検査学(〒606-8397 京都市左京区聖護院川原町54)
*2京都大学化学研究所生体反応設計研究部門 III(〒611-0011宇治市五ヶ庄)

E-mail :kosugi@kuhp.kyoto.ac.jp